HD

A25 Metabolism of sialo-conjugates is defective in pre-clinical models of huntington’s disease
Giuseppe Pepe, Enrico Amico, Salvatore Castaldo, Luca Capocci, Thomas J Boltje, Alba Di Pardo, Vittorio Maglione

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A9; DOI: 10.1136/jnnp-2018-EHDN.23
I17 Curcumin-supplemented diet preserves body weight and ameliorates intestinal functionality in R6/2 mice
Francesca Elifani, Salvatore Castaldo, Luca Capocci, Paolo Rosa, Elena Montano, Antonella Calogero, Stefania Filosa, Stefania Crispi, Vittorio Maglione, Alba Di Pardo

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A94-A95; DOI: 10.1136/jnnp-2018-EHDN.253
C05 BRCA mutations are associated with higher CAG numbers found in various polyglutamine disorders
Elisabeth Singer, Ilnaz Sepahi, Annika Sachs dos Santos, Cansu-Ebru Oender, André Koch, Andreas Hartkopf, Olaf Riess, Christopher Schroeder, Huu P Nguyen

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A28; DOI: 10.1136/jnnp-2018-EHDN.76
I16 Stimulation of SPHK1 with selective activator K6PC-5 is beneficial in the transgenic R6/2 mouse model of huntington disease
Alba Di Pardo, Salvatore Castaldo, Luca Capocci, Alfredo Giovannelli, Enrico Amico, Se Kyoo Jeong, Vittorio Maglione

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A94; DOI: 10.1136/jnnp-2018-EHDN.252
I15 Inhibition of S1P degradation is beneficial in the transgenic R6/2 mouse model of huntington disease
Alba Di Pardo, Salvatore Castaldo, Enrico Amico, Luca Capocci, Giuseppe Pepe, Vittorio Maglione

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A93-A94; DOI: 10.1136/jnnp-2018-EHDN.251
A27 Targeting glutamine dehydrogenase activity to induce autophagy and ameliorate neuronal degeneration; studies using a drosophila model for huntington’ disease
Paola Bellosta, Chiara Paiardi, Maria E Pasini

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A9-A10; DOI: 10.1136/jnnp-2018-EHDN.25
L14 Inhibition of mitochondrial permeability transition pore (MPTP), by GNX-4728, is beneficial in an in-vitro huntington’s disease model
Enrico Amico, Katiusha Martinello, Federica Draghi, Ennio Cavalletti, Sergio Fucile, Vittorio Maglione, Alba Di Pardo

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A94-A95; DOI: 10.1136/jnnp-2016-314597.269
L17 Selective stimulation of shingosine-1-phosphate receptors (S1PRS) is beneficial in huntington’s disease pre-clinical models
Alba Di Pardo, Enrico Amico, Salvatore Castaldo, Luca Capocci, Vittorio Maglione

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A95-A96; DOI: 10.1136/jnnp-2016-314597.272
C12 A new setup of the discrimination test as part of an assessment battery for phenotyping minipigs transgenic for huntington’s disease
Lorena Rieke, Sarah Schramke, Tamara Matheis, Robin Schubert, Frauke Freisfeld, Jan Motlik, Verena Schuldenzucker, Ralf Reilmann

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A31; DOI: 10.1136/jnnp-2016-314597.92
C14 A stress level test as part of an assessment battery for phenotyping minipigs transgenic for huntington’s disease
Verena Schuldenzucker, Robin Schubert, Frauke Freisfeld, Lorena Rieke, Tamara Matheis, Jan Motlik, Sarah Schramke, Ralf Reilmann

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A31-A32; DOI: 10.1136/jnnp-2016-314597.94

Main menu

HD

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

HD

Pages